Related content

Targeting B cells with biologics in systemic lupus erythematosus

By La Cava Antonio  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 11, 2010-11 ,pp. : 1555-1561

Informa Healthcare

Access to resources Recommend Favorite

Systemic lupus erythematosus: an update on current pharmacotherapy and future directions

By Touma Zahi   Urowitz Murray B   Gladman Dafna D  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 723-737

Informa Healthcare

Access to resources Recommend Favorite

Abatacept for systemic lupus erythematosus: the outlook

By Mok Chi Chiu  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1559-1561

Informa Healthcare

Access to resources Recommend Favorite

Belimumab for the management of systemic lupus erythematosus

By Lutalo Pamela M K   D'Cruz David P  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 7, 2012-07 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite

TWEAK as a target for therapy in systemic lupus erythematosus

By Leng Rui-Xue   Pan Hai-Feng   Qin Wei-Zi   Wang Chao   Chen Li-Li   Tao Jin-Hui   Ye Dong-Qing  

Molecular Biology Reports, Vol. 38, Iss. 1, 2011-01 ,pp. : 587-592

Springer Publishing Company

Access to resources Recommend Favorite